Cargando…
Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response
Pancreatic cancer, hepatocellular carcinoma (HCC), and mesothelioma are treatment-refractory cancers, and patients afflicted with these cancers generally have a very poor prognosis. The genomics of these tumors were analyzed as part of The Cancer Genome Atlas (TCGA) project. However, these analyses...
Autores principales: | Scaria, George S., Kren, Betsy T., Klein, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169466/ https://www.ncbi.nlm.nih.gov/pubmed/32033319 http://dx.doi.org/10.3390/ph13020026 |
Ejemplares similares
-
Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
por: Trembley, Janeen H., et al.
Publicado: (2022) -
Inhibition of Mitochondrial Antioxidant Defense and CDK4/6 in Mesothelioma
por: Kratzke, Marian, et al.
Publicado: (2023) -
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
por: Kren, Betsy T, et al.
Publicado: (2015) -
Cyclin D1 extensively reprograms metabolism to support biosynthetic pathways in hepatocytes
por: Wu, Heng, et al.
Publicado: (2023) -
Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)